XML 95 R35.htm IDEA: XBRL DOCUMENT v3.20.1
INCOME TAXES (Tables)
12 Months Ended
Dec. 31, 2019
Income Tax Disclosure [Abstract]  
Components of Pre-tax Income (Loss)
The following table sets forth the components of the Company's loss before income taxes by country (in thousands):
 
Year ended December 31,
 
2019
 
2018
 
2017
Country:
 
 
 
 
 
United States
$
(27,468
)
 
$
(15,977
)
 
$
(9,246
)
Canada
(80,032
)
 
(17,716
)
 
(19,783
)
Total Loss before Income Taxes
$
(107,500
)
 
$
(33,693
)
 
$
(29,029
)
Reconciliation of Expected Income Tax Expense
The following table sets forth a reconciliation of the statutory United States federal income tax rate to the Company’s effective income tax rate:
 
Year ended December 31,
 
2019
 
2018
 
2017
United States federal statutory income tax rate
21.0
 %
 
21.0
 %
 
34.0
 %
Impact of foreign rate differential
4.4

 
1.6

 
(2.6
)
State taxes, net of federal benefit
0.6

 
1.3

 
1.4

Stock option cancellations

 
(1.2
)
 
(0.8
)
Contingent consideration
(18.0
)
 
(5.5
)
 
(10.7
)
General business credits and other credits
0.4

 
0.7

 
0.8

Permanent differences

 
(0.3
)
 
0.3

Other
(0.5
)
 
0.5

 

United States federal statutory tax rate change

 

 
(50.6
)
Change in valuation allowance
(7.9
)
 
(18.1
)
 
28.2

Effective Income Tax Rate
 %
 
 %
 
 %
Components of Deferred Tax Assets and Liabilities
The following table sets forth the tax effects of temporary differences that gave rise to significant portions of the Company's deferred tax assets and liabilities (in thousands):
 
 
December 31,
 
2019
 
2018
Deferred tax assets:
 
 
 
NOL carryforwards
$
50,727

 
$
43,212

R&D credit carryforwards
4,385

 
3,876

Accruals and other
2,464

 
2,011

Capitalized start-up costs
91

 
122

Other
57

 
32

Gross deferred tax assets
57,724

 
49,253

Deferred tax liabilities:
 
 
 
IPR&D
(12,528
)
 
(12,528
)
Property and equipment

 
(60
)
Gross deferred tax liabilities
(12,528
)
 
(12,588
)
Valuation allowance
(57,724
)
 
(49,193
)
Net Deferred Tax Liability
$
(12,528
)
 
$
(12,528
)
Schedule of Credit Carryforwards
The following table summarizes the Company's NOL and R&D and other credit carryforwards in the United States and Canada as of December 31, 2019 (in millions):
 
Amount
 
Expiration Beginning in
 
Through
United States:
 
 
 
 
 
Federal NOL carryforwards - indefinite
$
41.2

 
None
 
None
Federal NOL carryforwards
$
118.9

 
2030
 
2039
State NOL carryforwards
$
131.2

 
2030
 
2039
Federal R&D credit carryforwards
$
2.2

 
2027
 
2039
State R&D credit carryforwards
$
0.9

 
2027
 
2039
Canada:
 
 
 
 
 
Federal non-capital loss carryforwards
$
32.6

 
2035
 
2039
Federal scientific research and experimental development expense carryforwards
$
6.2

 
2032
 
2039
Federal and provincial investment tax credit carryforwards
$
1.5

 
2032
 
2039